Me.CroS.A.Active
Research and experimental development on biotechnology
KRS: 0000960764 NIP: 5423446131 REGON: 52150297100000
Overview
Registry date
2022-03-17
Share capital
$27,012.43
Registered address
Ul. Hurtowa 4/7, 15-399 Białystok, Poland
Website
me-cro.comWebsite inactive
Electronic delivery address
AE:PL-78219-81551-SGSCC-36
Industry
| Name | Code |
|---|---|
Research and experimental development on biotechnologyPrimary | 72.11.Z |
Other research and experimental development on natural sciences and enginee ring | 72.19 |
Other professional, scientific and technical activities not elsewhere classified | 74.9 |
Leasing of intellectual property and similar products, except copyrighted works | 77.4 |
Food quality testing and analysis | 71.20.A |
Accounts
Registered as a VAT taxpayer on 2022-05-01.Active
- 22 1090 2590 0000 0001 4934 6233
- 92 1090 2590 0000 0001 4934 6234
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| PellicarnosS.A. | $135,043.43 | pellicarnos.com | |
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | |
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl/contact/wpdsa/ | |
| DigitmedS.A. | $64,087.41 | digitmed.pl | |
| InventroS.A. | $12,176.61 | inventro.co | |
| ArthecS.A. | $10,911.16 | arthec.eu | |
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | |
| 4cell TherapiesS.A. | $838.64 | 4celltherapies.com | |
| UrtesteS.A. | $324.85 | urteste.com | |
| Ncage TherapeuticsS.A. | $29.14 | ncage.org |
FAQ
Last updated: 2026-03-22